ZAP Surgical Receives CE Mark Clearance for its ZAP-X Gyroscopic Radiosurgery Platform Share Article ZAP-X Gyroscopic Radiosurgery platform SAN CARLOS, Calif. (PRWEB) February 02, 2021 ZAP Surgical Systems, Inc. today announced it has received CE mark clearance to the new EU MDR for its ZAP-X® Gyroscopic Radiosurgery® platform. The CE mark makes it possible for healthcare providers to begin treating patients with the ZAP-X system in the European Union. For select indications including many primary and metastatic brain tumors, stereotactic radiosurgery (SRS) is proven to be an effective alternative to invasive surgeries. As a non-invasive outpatient procedure with no surgical incision and little to no recovery period, SRS often improves patient quality of life while significantly reducing costs of care.